Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active control comparisons: the ideal trial design.

Martin J Brodie, John Whitehead

    Epilepsy Research
    |December 27, 2005
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Do the third-generation antiseizure medications provide the "magic bullet" for drug-resistant epilepsy? Focus on cenobamate.

    Epilepsia·2025
    Same author

    Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy.

    Epilepsia open·2025
    Same author

    The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.

    Epilepsia open·2024
    Same author

    Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis.

    Rheumatology (Oxford, England)·2024
    Same author

    Editorial: Epidemiology of epilepsy and seizures.

    Frontiers in epidemiology·2024
    Same author

    Discussion on "The central role of the identifying assumption in population size estimation" by Serge Aleshin-Guendel, Mauricio Sadinle, and Jon Wakefield.

    Biometrics·2024
    Same journal

    Comment on "Predictors of surgical outcome in frontal lobe epilepsy: Experience from a single-center cohort in Latin America".

    Epilepsy research·2026
    Same journal

    Response to: "A critical appraisal of principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam".

    Epilepsy research·2026
    Same journal

    Access to inpatient video-EEG monitoring for patients with frequent seizure-related emergency visits.

    Epilepsy research·2026
    Same journal

    Effect of the ketogenic diet on absence seizures in rats with genetic absence epilepsy.

    Epilepsy research·2026
    Same journal

    Diagnostic accuracy of artificial intelligence models for seizure outcome prediction after epilepsy surgery: A systematic review and meta-analysis.

    Epilepsy research·2026
    Same journal

    Quality assessment of persian epilepsy mobile applications: A systematic review using uMARS and DISCERN.

    Epilepsy research·2026
    See all related articles

    This clinical trial concept uses carbamazepine as a benchmark for newly diagnosed patients. It outlines efficacy, tolerability endpoints, and interim analyses for reliable and efficient study conclusions.

    Area of Science:

    • Clinical trial design
    • Pharmacology
    • Neurology

    Background:

    • Carbamazepine is an established treatment for newly diagnosed patients.
    • Optimizing clinical trial efficiency and reliability is crucial for drug development.

    Purpose of the Study:

    • To propose a clinical trial concept for evaluating new treatments against carbamazepine.
    • To define efficacy and tolerability endpoints for the study.
    • To implement a stopping rule using interim analyses for efficient and reliable conclusions.

    Main Methods:

    • Utilizing carbamazepine as the gold-standard active control.
    • Defining a composite endpoint encompassing both efficacy and tolerability.
    • Employing a sequential design with interim analyses to monitor study progress.

    Related Experiment Videos

    Main Results:

    • The proposed design allows for efficient decision-making.
    • Interim analyses enhance reliability without compromising statistical power.
    • The study aims to provide a robust comparison of new agents to carbamazepine.

    Conclusions:

    • This trial concept offers a framework for efficient and reliable drug evaluation.
    • The use of carbamazepine as a control and interim analyses ensures a rigorous study.
    • The proposed methodology can accelerate the development of new treatments for patients.